Specialty Pharmacy

Denmark is close to eradicating HIV through a prevention approach.

Risk of developing breast cancer in women with a BRCA1 mutation may be reduced.

Study finds new technique may improve treatment of diabetes.

Fingolimod (Gilenya) has shown inconsistent improvements with disability in multiple sclerosis.

Various benefits associated with fingolimod (Gilenya) observed for relapsing-remitted multiple sclerosis.

Women diagnosed with breast cancer who carry a BRCA mutation have up to a 50% lifetime risk of developing a second breast cancer.

Rovalpituzumab tesirine reduced tumor growth and even shrank tumors in some patients with small cell lung cancer.

Patients treated with chemotherapy and IMAB362 had a median overall survival of 16.7 months.

Bortezomib and dexamethasone slowed disease progression in patients with recurrent or refractory multiple myeloma.

Association found between persistent immune activation, arterial inflammation, and plaque development in HIV

Postmenopausal women with early breast cancer showed a reduction in disease recurrence after 10 years of aromatase inhibitor therapy with letrozole.

Targeted treatment shows strongest efficacy in HER2 abnormalities.

Ultrasound and chemotherapy in conjunction with microbubbles enhances pancreatic cancer treatment.

Biosimilar trastuzumab antibody (MYL-1401O) comparable in efficacy and safety to targeted cancer drug in women with HER2-positive advanced breast cancer.

Patients receiving intraperitoneal and intravenous chemotherapy had progression-free survival of 59.3 months.

Capecitabine chemotherapy in combination with gemcitabine show median overall survival rate of 28 months.

Anaplastic glioma patients administered temozolomide after radiation, with or without concurrent temozolomide, saw a slower progression of the disease.

Precision medicine found to be associated with increased tumor reduction and progression-free survival.

Access to new cancer medications varies greatly by country.

Overall 3-year survival in patients with advanced melanoma taking pembrolizumab was 40%.

Study finds link between marital bliss and greater risk of diabetes development.

Study finds need for updated pricing system for hepatitis C virus medications.

Thiazole benzensulfonamides (TZB) show useful anticancer properties.

Alcohol found to affect biologic mechanisms that raise the risk of cancer.

Hsp90 inhibitors target and inactivate a mechanism that cancer cells use to evade standard treatments.

Linagliptin and metformin hydrochloride extended-release tablets approved for adults with type 2 diabetes.

Family caregivers of patients with terminal cancers could benefit from early palliative care.

Growing use of payer rebates among drivers of US drug spending increase.